<DOC>
	<DOCNO>NCT02903212</DOCNO>
	<brief_summary>The aim study determine tolerance apoptotic autologous cell injection subject active rheumatoid arthritis .</brief_summary>
	<brief_title>Tolerance Effectiveness Cell Therapy Autologous Apoptotic Cells Treatment Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Patients diagnosis Rheumatoid arthritis Therapy failure least one biological agent antiTNFalpha ( etanercept , infliximab , adalimumab , certolizumab golimumab ; 3 month optimal dose ) , antiIL6 ( tocilizumab ; 3 month ) ; Tcell costimulatory pathway inhibitor ( abatacept ; 3 month ) ; antiCD20 ( rituximab ; 6 month optimal dose ) ; Anti IL1 ( anakinra ; 3 month ) Disease Activity Score ( DAS ) DAS28 â‰¥ 3.2 Subject provide write informed consent Pregnant lactate woman Inflammatory arthritis rheumatoid arthritis History invasive cancer Immunodeficiency ( HIV infection , Immunosuppressive therapy ) Active bacterial viral infection , particular HCV HBV . Surgery old 4 week . Unstable comorbidities : uncontrolled diabetes , heart disease , advance renal hepatic impairment . Contraindication apheresis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Apoptotic cell</keyword>
</DOC>